Alembic Pharmaceuticals Limited (NSE:APLLTD)
India · Delayed Price · Currency is INR 956.95
+14.20 (1.51%)
Aug 14, 2025, 3:30 PM IST
Alembic Pharmaceuticals Market Cap
Alembic Pharmaceuticals has a market cap or net worth of 188.10 billion as of August 15, 2025. Its market cap has decreased by -18.49% in one year.
Market Cap
188.10B
Enterprise Value
199.83B
Revenue
68.21B
Ranking
n/a
PE Ratio
31.18
Stock Price
956.95
Market Cap Chart
Since September 21, 2011, Alembic Pharmaceuticals's market cap has increased from 9.00B to 188.10B, an increase of 1,989.63%. That is a compound annual growth rate of 24.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 188.10B | -10.25% |
| Dec 31, 2024 | 209.59B | 40.41% |
| Dec 29, 2023 | 149.27B | 32.55% |
| Dec 30, 2022 | 112.61B | -28.56% |
| Dec 31, 2021 | 157.62B | -22.43% |
| Dec 31, 2020 | 203.20B | 88.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,938.27B |
| Divi's Laboratories | 1,627.99B |
| Cipla | 1,263.32B |
| Apollo Hospitals Enterprise | 1,124.61B |
| Mankind Pharma | 1,020.51B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 703.62B |
| Alkem Laboratories | 639.37B |